Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial.
Yijun HuaRui YouZhiqiang WangPeiyu HuangMei LinYanfeng OuyangYulong XieXiong ZouYouping LiuChongyang DuanYonglong LiuChenmei GuRongzeng LiuQi YangRou JiangMengxia ZhangXi DingSiyuan ChenChao LinRui SunMingyuan ChenPublished in: Journal for immunotherapy of cancer (2022)
NCT03854838.